Zhang Ming-Rong, Furutsuka Kenji, Maeda Jun, Kikuchi Tatsuya, Kida Takayo, Okauchi Takashi, Irie Toshiaki, Suzuki Kazutoshi
Department of Medical Imaging, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Bioorg Med Chem. 2003 Jun 12;11(12):2519-27. doi: 10.1016/s0968-0896(03)00177-9.
N-[(18)F]Fluoroethyl-4-piperidyl acetate ([(18)F]FEtP4A) was synthesized and evaluated as a PET tracer for imaging brain acetylcholinesterase (AchE) in vivo. [(18)F]FEtP4A was previously prepared by reacting 4-piperidyl acetate (P4A) with 2-[(18)F]fluoroethyl bromide ([(18)F]FEtBr) at 130 degrees C for 30 min in 37% radiochemical yield using an automated synthetic system. In this work, [(18)F]FEtP4A was synthesized by reacting P4A with 2-[(18)F]fluoroethyl iodide ([(18)F]FEtI) or 2-[(18)F]fluoroethyl triflate ([(18)F]FEtOTf in improved radiochemical yields, compared with [(18)F]FEtBr under the corresponding condition. Ex vivo autoradiogram of rat brain and PET summation image of monkey brain after iv injection of [(18)F]FEtP4A displayed a high radioactivity in the striatum, a region with the highest AchE activity in the brain. Moreover, the distribution pattern of (18)F radioactivity was consistent with that of AchE in the brain: striatum>frontal cortex>cerebellum. In the rat and monkey plasma, two radioactive metabolites were detected. However, their presence might not preclude the imaging studies for AchE in the brain, because they were too hydrophilic to pass the blood-brain barrier and to enter the brain. In the rat brain, only [(18)F]fluoroethyl-4-piperidinol ([(18)F]FEtP4OH) was detected at 30 min postinjection. The hydrolytic [(18)F]FEtP4OH displayed a slow washout and a long retention in the monkey brain until the PET experiment (120 min). Although [(18)F]FEtP4A is a potential PET tracer for imaging AchE in vivo, its lower hydrolytic rate and lower specificity for AchE than those of [(11)C]MP4A may limit its usefulness for the quantitative measurement for AchE in the primate brain.
N-[(18)F]氟乙基-4-哌啶基乙酸酯([(18)F]FEtP4A)被合成,并作为一种正电子发射断层扫描(PET)示踪剂用于体内脑乙酰胆碱酯酶(AchE)成像评估。[(18)F]FEtP4A先前是通过使用自动化合成系统,使4-哌啶基乙酸酯(P4A)与2-[(18)F]氟乙基溴([(18)F]FEtBr)在130℃下反应30分钟,以37%的放射化学产率制备的。在本研究中,[(18)F]FEtP4A是通过使P4A与2-[(18)F]氟乙基碘([(18)F]FEtI)或2-[(18)F]氟乙基三氟甲磺酸酯([(18)F]FEtOTf)反应合成的,与相应条件下的[(18)F]FEtBr相比,放射化学产率有所提高。静脉注射[(18)F]FEtP4A后大鼠脑的离体放射自显影图和猴脑的PET叠加图像显示纹状体放射性很高,纹状体是脑中AchE活性最高的区域。此外,(18)F放射性的分布模式与脑中AchE的分布模式一致:纹状体>额叶皮质>小脑。在大鼠和猴血浆中检测到两种放射性代谢物。然而,它们的存在可能并不妨碍对脑中AchE的成像研究,因为它们亲水性太强,无法通过血脑屏障进入大脑。在大鼠脑中,注射后30分钟仅检测到[(18)F]氟乙基-4-哌啶醇([(18)F]FEtP4OH)。水解后的[(18)F]FEtP4OH在猴脑中显示出缓慢的清除和长时间的滞留,直到PET实验(120分钟)。尽管[(18)F]FEtP4A是一种用于体内AchE成像的潜在PET示踪剂,但其水解速率低于[(11)C]MP4A,对AchE的特异性也低于[(11)C]MP4A,这可能会限制其在灵长类动物脑中对AchE进行定量测量的用途。